当前位置: X-MOL 学术Epigenetics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis
Epigenetics ( IF 2.9 ) Pub Date : 2020-10-04 , DOI: 10.1080/15592294.2020.1827715
John Henderson 1 , Sarah Wilkinson 1 , Stefan Przyborski 2 , Richard Stratton 3 , Steven O'Reilly 2
Affiliation  

ABSTRACT

Systemic Sclerosis (SSc) is an autoimmune connective tissue disease that leads to skin and lung fibrosis. The Wnt pathway is clearly elevated in SSc and is pro-fibrotic via activation of canonical Wnt signalling. sFRP-1 is a Wnt antagonist that acts as a negative regulator of Wnt signalling. We sought to measure the levels of serum sFRP-1 in early diffuse SSc patients compared to healthy controls and if this is regulated by microRNA27a-3p. Ten early diffuse SSc patients and healthy controls sera were taken and sFRP-1 quantified by ELISA. Skin biopsies were also taken in five SSc patients and controls. Fibroblasts were quantified for microRNA27-3p expression by Taqman qRT-PCR with an internal microRNA to normalize. 3ʹUTR luciferase assays were performed to confirm direct targets of microRNA27a-3p with microRNA overexpression. Fibroblasts were transfected with microRNA27a mimics or scramble controls and using ELISA sFRP-1 was quantified. Furthermore, Collagen, Axin-2, TIMP-1 and MMP-1 were measured. Serum sFRP-1 was significantly reduced in early diffuse SSc patients. We identified microRNA27a-3p-3p as regulating sFRP-1 in dermal fibroblasts. We found significantly elevated microRNA27a-3p in isolated dermal fibroblasts from SSc patients. We confirmed that sFRP-1 is a direct target of microRNA27a-3p through cloning of the 3ʹUTR into a luciferase vector. ECM genes were also upregulated by microRNA27a-3p-3p and the matrix-degrading enzyme MMP-1 was suppressed. Serum sFRP-1 is reduced in diffuse SSc patients and is regulated by microRNA27a-3p and this is a direct regulation. Modulation of microRNA27a-3p levels could mediate fibrosis regression.



中文翻译:

microRNA27a-3p 介导 Wnt 拮抗剂 sFRP-1 在系统性硬化症中的减少

摘要

系统性硬化症 (SSc) 是一种自身免疫性结缔组织病,可导致皮肤和肺纤维化。Wnt 通路在 SSc 中明显升高,并通过激活经典 Wnt 信号传导促进纤维化。sFRP-1 是一种 Wnt 拮抗剂,可作为 Wnt 信号传导的负调节剂。我们试图测量早期弥漫性 SSc 患者与健康对照相比的血清 sFRP-1 水平,以及这是否受 microRNA27a-3p 的调节。采集 10 名早期弥漫性 SSc 患者和健康对照血清,并通过 ELISA 对 sFRP-1 进行定量。还对五名 SSc 患者和对照组进行了皮肤活检。通过 Taqman qRT-PCR 对成纤维细胞的 microRNA27-3p 表达进行量化,并使用内部 microRNA 进行标准化。进行 3'UTR 荧光素酶测定以确认 microRNA27a-3p 的直接靶标与 microRNA 过表达。用 microRNA27a 模拟物或乱序对照转染成纤维细胞,并使用 ELISA 对 sFRP-1 进行量化。此外,还测量了胶原蛋白、Axin-2、TIMP-1 和 MMP-1。早期弥漫性 SSc 患者的血清 sFRP-1 显着降低。我们确定 microRNA27a-3p-3p 在真皮成纤维细胞中调节 sFRP-1。我们发现 SSc 患者分离的真皮成纤维细胞中的 microRNA27a-3p 显着升高。我们通过将 3ʹUTR 克隆到荧光素酶载体中证实了 sFRP-1 是 microRNA27a-3p 的直接靶标。ECM 基因也被 microRNA27a-3p-3p 上调,基质降解酶 MMP-1 被抑制。弥漫性 SSc 患者的血清 sFRP-1 降低,并受 microRNA27a-3p 的调节,这是一种直接调节。调节 microRNA27a-3p 水平可以介导纤维化消退。

更新日期:2020-10-04
down
wechat
bug